
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
Envista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally. The company is headquartered in Brea, California.
| Revenue (TTM) | $2.86B |
| Gross Profit (TTM) | $1.58B |
| EBITDA | $406.20M |
| Operating Margin | 10.40% |
| Return on Equity | 3.06% |
| Return on Assets | 3.23% |
| Revenue/Share (TTM) | $17.41 |
| Book Value | $19.16 |
| Price-to-Book | 1.24 |
| Price-to-Sales (TTM) | 1.35 |
| EV/Revenue | 1.501 |
| EV/EBITDA | 10.19 |
| Quarterly Earnings Growth (YoY) | 111.30% |
| Quarterly Revenue Growth (YoY) | 7.10% |
| Shares Outstanding | $160.62M |
| Float | $159.87M |
| % Insiders | 0.59% |
| % Institutions | 120.77% |
Volatility is currently expanding

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

SLDE, HHH and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 21st, 2026.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Envista Holdings Corporation (NVST) Presents at 2026 Global Healthcare Conference Transcript

Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

BREA, Calif., Sept. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2026 Global Healthcare Conference.

Envista (NVST) reported earnings 30 days ago. What's next for the stock?
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NVST and any ticker you trade — then tracks every position and per-strategy win rate.